Lyra Therapeutics Inc’s stock has had a calm market performance.
52-week price history of LYRA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Lyra Therapeutics Inc’s current trading price is 34.57% away from its 52-week high, while its distance from the 52-week low is 507.47%. The stock’s price range for this period has remained between $3.81 and $17.20. The Healthcare sector company’s shares managed to surpass a trading volume of around 23.11 million for the day, which was noticeably higher compared to the shares’ average daily volume of 69150.0 over the last three months.
Financial Performance and Market Capitalization
Lyra Therapeutics Inc (LYRA) has experienced a quarterly rise of 138.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.66M and boasts a workforce of 30 employees.
Moving average and trading volume data
LYRA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LYRA stands at 8.62. Similarly, the long-term debt-to-equity ratio is also 7.52.
LYRA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 124.28%. However, over the last six months, the performance has been weaker by 133.44%. The price of LYRA increased 315.16% over the last 30 days. And in the last five days, it has surged by 404.25%.
